Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS | $1.4 | $6.7 | $14.0 | $8.1 | $3.8 | $12.5 | ($2.2) | $7.3 | $2.2 | $2.7 | $2.4 | $1.5 | ($0.0) | ($7.8) | $0.8 | $4.2 | $8.9 | $2.2 |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Capital Product Partners L.P.'s last 12-month EPS is $2.6, based on the financial report for Jun 30, 2024 (Q2 2024).
Over the last year, Capital Product Partners L.P.'s EPS growth was (52.1%). The average annual EPS growth rates for Capital Product Partners L.P. have been 16.8% over the past three years, N/A over the past five years.
Over the last year, Capital Product Partners L.P.'s EPS growth was (52.1%), which is lower than industry growth of (0.4%). It indicates that Capital Product Partners L.P.'s EPS growth is Bad.